Article Text

Download PDFPDF
Clinical trials in gynecological cancer
  1. E. L. Trimble,
  2. J. Davis,
  3. P. Disaia,
  4. K. Fujiwara,
  5. D. Gaffney,
  6. G. Kristensen,
  7. J. Ledermann,
  8. J. Pfisterer,
  9. M. Quinn,
  10. N. Reed,
  11. M. Schoenfeldt,
  12. J. T. Thigpen,
  1. National Cancer Institute—Cancer Therapy Evaluation Program; North Glasgow University Hospitals NHS Trust; University of California Medical Center at Irvine; Saitama Medical University, Huntsman Cancer Hospital—University of Utah; Norwegian Radium Hospital; Cancer Research UK and UCL Cancer Trials Centre; Universitätsklinikum Schleswig-Holstein Campus Kiel; University of Melbourne; Beatson Oncology Centre; The EMMES Corporation; and University of Mississippi School of Medicine
  1. Address correspondence and reprint requests to: Edward L. Trimble, MD, MPH, Lancer Therapy Evaluation Program, National Cancer Institute, Room 741, MSC 7436, 6130 Executive Blvd., Bethesda, MD 20892. Email: trimblet{at}


The Gynecologic Cancer Intergroup is comprised representatives from international gynecological cancer trials organizations, which collaborate in multicenter studies to answer the clinical challenges in gynecological cancer. This review article highlights the key clinical questions facing clinical trialists over the next decade, the information and infrastructure resources available for trials, and the methods of trial development. We cover human papillomavirus (HPV)-associated neoplasia, including cervical cancer, together with endometrial cancer, ovarian cancer, and vulvar cancer. Infrastructure for clinical trials includes a database for trials, templates for protocol development, patient educational material, and financial support for clinical trials. Other critical issues include support from government and charities and government regulations.

  • gynecologic cancer
  • ovarian cancer
  • cervical cancer
  • endometrial cancer
  • clinical trials
  • GCIG

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.